Syringin Prevents 6-Hydroxydopamine Neurotoxicity by Mediating the MiR-34a/SIRT1/Beclin-1 Pathway and Activating Autophagy in SH-SY5Y Cells and the <i>Caenorhabditis elegans</i> Model

Defective autophagy is one of the cellular hallmarks of Parkinson’s disease (PD). Therefore, a therapeutic strategy could be a modest enhancement of autophagic activity in dopamine (DA) neurons to deal with the clearance of damaged mitochondria and abnormal protein aggregates. Syringin (SRG) is a ph...

Full description

Bibliographic Details
Main Authors: Ru-Huei Fu, Syuan-Yu Hong, Hui-Jye Chen
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/12/18/2310
_version_ 1797580832366395392
author Ru-Huei Fu
Syuan-Yu Hong
Hui-Jye Chen
author_facet Ru-Huei Fu
Syuan-Yu Hong
Hui-Jye Chen
author_sort Ru-Huei Fu
collection DOAJ
description Defective autophagy is one of the cellular hallmarks of Parkinson’s disease (PD). Therefore, a therapeutic strategy could be a modest enhancement of autophagic activity in dopamine (DA) neurons to deal with the clearance of damaged mitochondria and abnormal protein aggregates. Syringin (SRG) is a phenolic glycoside derived from the root of <i>Acanthopanax senticosus</i>. It has antioxidant, anti-apoptotic, and anti-inflammatory properties. However, whether it has a preventive effect on PD remains unclear. The present study found that SRG reversed the increase in intracellular ROS-caused apoptosis in SH-SY5Y cells induced by neurotoxin 6-OHDA exposure. Likewise, in <i>C. elegans,</i> degeneration of DA neurons, DA-related food-sensitive behaviors, longevity, and accumulation of α-synuclein were also improved. Studies of neuroprotective mechanisms have shown that SRG can reverse the suppressed expression of SIRT1, Beclin-1, and other autophagy markers in 6-OHDA-exposed cells. Thus, these enhanced the formation of autophagic vacuoles and autophagy activity. This protective effect can be blocked by pretreatment with wortmannin (an autophagosome formation blocker) and bafilomycin A1 (an autophagosome–lysosome fusion blocker). In addition, 6-OHDA increases the acetylation of Beclin-1, leading to its inactivation. SRG can induce the expression of SIRT1 and promote the deacetylation of Beclin-1. Finally, we found that SRG reduced the 6-OHDA-induced expression of miR-34a targeting <i>SIRT1</i>. The overexpression of miR-34a mimic abolishes the neuroprotective ability of SRG. In conclusion, SRG induces autophagy via partially regulating the miR-34a/SIRT1/Beclin-1 axis to prevent 6-OHDA-induced apoptosis and α-synuclein accumulation. SRG has the opportunity to be established as a candidate agent for the prevention and cure of PD.
first_indexed 2024-03-10T22:56:36Z
format Article
id doaj.art-c05f9e804a54401aa1cf4f88708ef68c
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-10T22:56:36Z
publishDate 2023-09-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-c05f9e804a54401aa1cf4f88708ef68c2023-11-19T10:00:14ZengMDPI AGCells2073-44092023-09-011218231010.3390/cells12182310Syringin Prevents 6-Hydroxydopamine Neurotoxicity by Mediating the MiR-34a/SIRT1/Beclin-1 Pathway and Activating Autophagy in SH-SY5Y Cells and the <i>Caenorhabditis elegans</i> ModelRu-Huei Fu0Syuan-Yu Hong1Hui-Jye Chen2Graduate Institute of Biomedical Sciences, China Medical University, Taichung 40402, TaiwanGraduate Institute of Biomedical Sciences, China Medical University, Taichung 40402, TaiwanGraduate Institute of Biomedical Sciences, China Medical University, Taichung 40402, TaiwanDefective autophagy is one of the cellular hallmarks of Parkinson’s disease (PD). Therefore, a therapeutic strategy could be a modest enhancement of autophagic activity in dopamine (DA) neurons to deal with the clearance of damaged mitochondria and abnormal protein aggregates. Syringin (SRG) is a phenolic glycoside derived from the root of <i>Acanthopanax senticosus</i>. It has antioxidant, anti-apoptotic, and anti-inflammatory properties. However, whether it has a preventive effect on PD remains unclear. The present study found that SRG reversed the increase in intracellular ROS-caused apoptosis in SH-SY5Y cells induced by neurotoxin 6-OHDA exposure. Likewise, in <i>C. elegans,</i> degeneration of DA neurons, DA-related food-sensitive behaviors, longevity, and accumulation of α-synuclein were also improved. Studies of neuroprotective mechanisms have shown that SRG can reverse the suppressed expression of SIRT1, Beclin-1, and other autophagy markers in 6-OHDA-exposed cells. Thus, these enhanced the formation of autophagic vacuoles and autophagy activity. This protective effect can be blocked by pretreatment with wortmannin (an autophagosome formation blocker) and bafilomycin A1 (an autophagosome–lysosome fusion blocker). In addition, 6-OHDA increases the acetylation of Beclin-1, leading to its inactivation. SRG can induce the expression of SIRT1 and promote the deacetylation of Beclin-1. Finally, we found that SRG reduced the 6-OHDA-induced expression of miR-34a targeting <i>SIRT1</i>. The overexpression of miR-34a mimic abolishes the neuroprotective ability of SRG. In conclusion, SRG induces autophagy via partially regulating the miR-34a/SIRT1/Beclin-1 axis to prevent 6-OHDA-induced apoptosis and α-synuclein accumulation. SRG has the opportunity to be established as a candidate agent for the prevention and cure of PD.https://www.mdpi.com/2073-4409/12/18/2310Parkinson’s diseasesyringinSH-SY5Y cells6-hydroxydopamine (6-OHDA)autophagyBeclin-1
spellingShingle Ru-Huei Fu
Syuan-Yu Hong
Hui-Jye Chen
Syringin Prevents 6-Hydroxydopamine Neurotoxicity by Mediating the MiR-34a/SIRT1/Beclin-1 Pathway and Activating Autophagy in SH-SY5Y Cells and the <i>Caenorhabditis elegans</i> Model
Cells
Parkinson’s disease
syringin
SH-SY5Y cells
6-hydroxydopamine (6-OHDA)
autophagy
Beclin-1
title Syringin Prevents 6-Hydroxydopamine Neurotoxicity by Mediating the MiR-34a/SIRT1/Beclin-1 Pathway and Activating Autophagy in SH-SY5Y Cells and the <i>Caenorhabditis elegans</i> Model
title_full Syringin Prevents 6-Hydroxydopamine Neurotoxicity by Mediating the MiR-34a/SIRT1/Beclin-1 Pathway and Activating Autophagy in SH-SY5Y Cells and the <i>Caenorhabditis elegans</i> Model
title_fullStr Syringin Prevents 6-Hydroxydopamine Neurotoxicity by Mediating the MiR-34a/SIRT1/Beclin-1 Pathway and Activating Autophagy in SH-SY5Y Cells and the <i>Caenorhabditis elegans</i> Model
title_full_unstemmed Syringin Prevents 6-Hydroxydopamine Neurotoxicity by Mediating the MiR-34a/SIRT1/Beclin-1 Pathway and Activating Autophagy in SH-SY5Y Cells and the <i>Caenorhabditis elegans</i> Model
title_short Syringin Prevents 6-Hydroxydopamine Neurotoxicity by Mediating the MiR-34a/SIRT1/Beclin-1 Pathway and Activating Autophagy in SH-SY5Y Cells and the <i>Caenorhabditis elegans</i> Model
title_sort syringin prevents 6 hydroxydopamine neurotoxicity by mediating the mir 34a sirt1 beclin 1 pathway and activating autophagy in sh sy5y cells and the i caenorhabditis elegans i model
topic Parkinson’s disease
syringin
SH-SY5Y cells
6-hydroxydopamine (6-OHDA)
autophagy
Beclin-1
url https://www.mdpi.com/2073-4409/12/18/2310
work_keys_str_mv AT ruhueifu syringinprevents6hydroxydopamineneurotoxicitybymediatingthemir34asirt1beclin1pathwayandactivatingautophagyinshsy5ycellsandtheicaenorhabditiselegansimodel
AT syuanyuhong syringinprevents6hydroxydopamineneurotoxicitybymediatingthemir34asirt1beclin1pathwayandactivatingautophagyinshsy5ycellsandtheicaenorhabditiselegansimodel
AT huijyechen syringinprevents6hydroxydopamineneurotoxicitybymediatingthemir34asirt1beclin1pathwayandactivatingautophagyinshsy5ycellsandtheicaenorhabditiselegansimodel